Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 2, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases, today announced the first patient dosing inAustralia on Dec 30, 2024 for Phase 1 cl...

2025-01-03 01:43 1953

Statement regarding the patent dispute between Cocrystal Technology and KANEKA Corporation in the United States

JIAXING, China, Jan. 2, 2025 /PRNewswire/ -- Cocrystal Technology Co., Ltd. ("Cocrystal"), a pioneer of applying drug cocrystal technology in nutritional solutions, has been named in a lawsuit filed by Kaneka Corporation inthe United States District Court for the Eastern District of New York (...

2025-01-02 21:30 2151

WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year

* Named for second consecutive year named to prestigious DJSI list * Leading green biologics solutions for a healthier future SHANGHAI, Jan. 2, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), t...

2025-01-02 17:30 1716

Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers

SAN FRANCISCO, Jan. 2, 2025 /PRNewswire/ -- Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, will present its latest breakthrough immunocytokine, FP008, onJan 14, 2025, at the Biotech Showcase investor conference, following J.P. Morgan Healthcare Week. This ...

2025-01-02 17:17 1091

FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections

SHANGHAI, Jan. 1, 2025 /PRNewswire/ -- Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx"，688373.SH) announced that MRX-5, its self-developed anti-infection drug, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment ofnon-tuberculous myco...

2025-01-02 12:52 1785

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

SHANGHAI, Dec. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the initiation of an investigator-initiated trial (IIT) inChina for K...

2024-12-31 21:50 2899

Ractigen Therapeutics Founder Dr. Long-Cheng Li Awarded 2024 Life Science Ice Breaking Award

NANTONG and SUZHOU, China, Dec. 31, 2024 /PRNewswire/ -- Ractigen Therapeutics proudly announces that its Founder and CEO, Dr.Long-Cheng Li, has been honored with the 2024 Life Science Ice Breaking Award. This award, established by Mr. Cai Lei, a prominent ALS patient and advocate, along with his ...

2024-12-31 20:00 1926

CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts

SEOUL, South Korea, Dec. 31, 2024 /PRNewswire/ -- CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a leading Korean orthopedic implant research and manufacturing company, partnered withCGBIO to host the International Spine Endoscopy Training Course. The event welcomed 12 medical professionals from nin...

2024-12-31 20:00 1732

CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts

Ping An Health Supported the Official Release of the "Group Standards for Remote and Internet-Based Family Doctor Healthcare Services"

HONG KONG and SHANGHAI, Dec. 31, 2024 /PRNewswire/ -- With Ping An Healthcare and Technology Company Limited's ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) strategic support, and guidance from the General Practice Development Research Center of Peking Universit...

2024-12-31 15:26 3592

Ping An Health Supported the Official Release of the

Duality Biologics Announces B7H4 ADC Milestone Achievement and License Exercise by BeiGene

SOMERSET, N.J., SHANGHAI and SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Duality Biologics ("DualityBio") announced that, BeiGene. Ltd. has exercised its exclusive option for the B7H4 antibody-drug conjugate (ADC) DB1312/BG-C9074 from DualityBio, securing global development, manufacturing, and ...

2024-12-31 08:00 1726

I Peace manufactures 100 lines of GMP iPS Cells cumulatively

Proof of customer recognition of its quality and mass manufacturing capability PALO ALTO, Calif., Dec. 30, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/ ), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell ther...

2024-12-31 04:24 1142

Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SEONGNAM, South Korea and BOSTON, Dec. 30, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer, today announced that James Jungkue Lee, Founder and CEO of Bridge Biotherapeutics, will present ...

2024-12-30 23:00 2196

CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel)

SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the positive results from the pivotal Phase II clinical trial CT041-...

2024-12-30 21:50 2109

WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year

SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that it has been recognized by the prestigious Dow Jones Sustainability Indices ...

2024-12-30 20:00 1955

Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726

SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd. (hereinafter referred to as "SynerK") have reache...

2024-12-30 13:00 1551

Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration

* Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler designed ...

2024-12-30 13:00 1638

Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration

Taiwanese Companies Lead Innovation in AI-Powered Smart Wearables

TAIPEI, Dec. 29, 2024 /PRNewswire/ -- In the rapidly evolving tech landscape, smart wearable devices enriched with artificial intelligence (AI) and augmented reality (AR) are redefining the boundaries of innovation. Leading the charge, members of the AI on Chip Industrial Cooperation Strategic Al...

2024-12-30 11:32 1611

Taiwanese Companies Lead Innovation in AI-Powered Smart Wearables

BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth

CHENGDU, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, today announced completion of the acquisition of the intelligent platform of AIX Inc. It marks BGM's official entry into the domains of AI intelligent t...

2024-12-27 22:30 7377

In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI

CHONGQING, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Stock Code: BGM) has successfully acquired Rongshu Technology and Xinbao Investment Company, both subsidiaries of AIX Corp. (Stock Code: AIFU), in a transaction valued at approximately$140 million. This acquisition presents substanti...

2024-12-27 22:05 6984

Fangzhou Inc. Honored as an "Outstanding Innovation Firm" by Yangcheng Evening News

GUANGZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored as an "Outstanding Innovation Firm" at the "Precision Engineering: 2024 Technology Pioneers Gala" held by Yangcheng Evening News onDecembe...

2024-12-27 17:30 3849

1 234 5 6 ... 283